Viewing Study NCT00984893


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-02-25 @ 5:43 PM
Study NCT ID: NCT00984893
Status: COMPLETED
Last Update Posted: 2016-03-04
First Post: 2009-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intra-venous Zoledronic Acid Once Yearly
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Post-Menopausal Osteoporosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osteoporosis View
None Bone Mineral density View
None fragility fractures View
None zoledronic acid. View
None Treatment View